new glp retatrutide 🎙️ EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in RETATRUTIDE | NEOPEPS

Why peptides are particularly challenging for sublingual delivery Peptides like semaglutide and tirzepatide are large molecules compared to many sublingual drugs

was supported in part by a graduate fellowship from the NSF (DGE-1747503) and by a Biotechnology Training Grant from NIGMS (T32 GM008349)

Tirzepatide produces superior weight loss (15-22% vs 10-15% with semaglutide) due to its dual GIP/GLP-1 mechanism

Pendulum includes Akkermansia and a small amount of inulin from chicory root acting as a prebiotic

The aim of this retrospective study is to report and analyze the results of the use of arGLP-1 in patients experiencing insufficient weight loss or weight regain after bariatric surgery

But now, three GLP-1 medications are FDA-approved specifically for weight loss: liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)